Amianto e mesoteliomi. I dati aggiornati sull'amianto e incidenza del mesotelioma in Liguria per gli anni 1994–2006, a cura del COR-ReNaM

Prevenzione in Piemonte. Presentata la bozza del Piano regionale di prevenzione della Regione Piemonte 2010-2012.On line i materiali relativi agli interventi dei relatori

Leucemia Linfoblastica Acuta. START ha aggiornato il capitolo sulla leucemia linfoblastica acuta, con dati epidemiologici, diagnosi e trattamento

Libretti sui tumori.
On line i testi integrali di 33 libretti pubblicati dall'AIMAC per fornire informazioni sulle varie neoplasie e sugli aspetti da affrontare per convivere con la malattia

 
 
 
 

Bibliografia dei testi sul tumore dello stomaco

Incidenza

  1. Coleman MP, Babb P, Daniecki P, et al. Cancer survival trends in England and Wales, 1971-1995: deprivation and NHS region. Studies in medical and population subjects No. 61. London: The Stationary Office. book 1999

  2. Ferlay J, Bray F, Sankila R, Parkin DM. Cancer incidence, mortality and prevalence in the European Union.Lyon: IARC Press. 1999

  3. Ferlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality and prevalence worldwide, version 1.0. Lyon: IARC Press. IARC Cancer Base No. 5. 2001

  4. Ferretti S, Gafa L. Upper gastrointestinal tract cancers: oesophagus, stomach, liver, gallbladder and biliary ducts, pancreas. Epidemiol Prev 2004; 28: 34-42

  5. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56: 1-9

Prevalenza

  1. Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, et al. Cancer prevalence in European registry areas. Ann Oncol 2002; 13: 840-865

Sopravvivenza

  1. Berrino F, Capocaccia R, Coleman MP, Esteve J, Gatta G, Hakulinen T, et al. Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 2003; 14 Suppl 5

  2. Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, Soderman B, et al. Survival of cancer patients in Finland 1955-1994. Acta Oncol 1999; 38 Suppl 12: 1-103

  3. Roazzi P, Capocaccia R, Santaquilani M, Carrani E. Electronic availability of EUROCARE-3 data: a tool for further analysis. Ann Oncol 2003; 14 Suppl 5:v150-5.: v150-v155

  4. Sant M, Aareleid T, Berrino F, Bielska LM, Carli PM, Faivre J, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol 2003; 14 Suppl 5:v61-118.: v61-118

  5. Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003; 39: 1603-1609

Eziologia

  1. Asaka M, Kudo M, Kato M, Sugiyama T, Takeda H. Review article: Long-term Helicobacter pylori infection--from gastritis to gastric cancer. Aliment Pharmacol Ther 1998; 12 Suppl 1:9-15

  2. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy . J Natl Cancer Inst 2000; 92: 1881-1888

  3. ESG. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-1362

  4. Gonzalez CA. For the EPIC working group on gastriccancer. Vegetable, fruit and cereal consumption and gastric cancer risk. In: Riboli E, Lambert R, editors. Nutrition and lifestyle: opportunities. Lyon: IARC Press. IARC Sc Publ No 156. 2002
  5. Gonzalez CA, Pera G, Agudo A, Palli D, Krogh V, Vineis P, et al. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer 2003; 107: 629-634

  6. Griem ML, Kleinerman RA, Boice JD, Jr., Stovall M, Shefner D, Lubin JH. Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst 1994; 86: 842-849

  7. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, et al.Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993; 71: 745-750

  8. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56: 1-9

  9. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992; 70: 50-55

  10. Lissowska J, Groves FD, Sobin LH, Fraumeni JF, Jr., Nasierowska-Guttmejer A, Radziszewski J, et al. Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev 1999; 8: 223-227

  11. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85

  12. Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 1994; 3: 15-18
  13. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, et al.

  14. Varis K, Taylor PR, Sipponen P, Samloff IM, Heinonen OP, Albanes D, et al. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol 1998; 33: 294-300

Testi prodotti da

Istituto Nazionale Tumori - Milano
Istituto Superiore di Sanità - Roma
Start Oncology
Associazione Italiana Registri Tumori
Associazione Italiana di Oncologia Medica
Istituto Nazionale per la Ricerca sul Cancro - Genova
Centro di Riferimento Oncologico - Aviano
Istituto per lo Studio e la Prevenzione Oncologica - Firenze
Fondazione Pascale - Napoli
Istituto Europeo Oncologico - Milano
Osservatorio Italiano Cure Palliative
Federazione Italiana Associazioni di Volontariato in Oncologia
Osservatorio Nazionale sulla salute 
              della Donna
Aderiamo allo standard HONcode per l'affidabilitą dell'informazione medica

 

 

Visite dall'1/6/2009